NETHERLANDS, 2038 – The urine sensor introduced in 2025 to detect cancer at an early stage has now become a standard article in most households. The number of people who die from cancer has strongly decreased since then, just like the healthcare costs. The sensor detects whether specific genes that point to cancer are present in the urine. This can indicate the presence of tumours. The chip was developed by Amsterdam UMC and the University of Twente.
NIJMEGEN, 2038 – Due to reduced medicine use, healthcare costs have further decreased in 2038. This trend started many years ago thanks to new medicines with a higher efficacy. Patients therefore require fewer medicines and experience fewer side effects. All of this is thanks to a discovery made by the Nijmegen biotech company Pharmacytics and Radboud University. They developed a chemical method to link medicinal substances to nutrients so that the body absorbs these better.
WAGENINGEN, 2038 – Now in 2038, ticks with the bacteria that cause Lyme disease are almost eradicated from the Netherlands and surrounding regions. This has become possible thanks to the “gene drive” technology and special detection and control methods that were developed many years ago by students at Wageningen University and Research. A new “clean” generation of ticks was cultured in the lab and released into the wild. In the future, tropical diseases will also be tackled in this way.
UTRECHT, 2038 – The number of rare hereditary diseases that can be successfully treated further rose in 2038. The trend was initiated by biotech company ProQR in Leiden, in collaboration with the University of Utrecht. They developed a method to correct errors in the genetic material (DNA) at the level of the “messenger RNA” which passes on the DNA code to the proteins. As a result, such diseases can now be treated by administering the medicine regularly without the need to change the “permanent” DNA code.
NETHERLANDS, 2038 – A new area has dawned for the almost 140 million psoriasis patients worldwide. This skin disease regularly requires irradiation with UV lamps under medical supervision. After many years of joint research, the University of Groningen, Utrecht University and Seaborough Life Sciences in Amsterdam have developed a special skin cream that converts blue light into UV radiation with the help of lanthanides in the nanoparticles in this cream. Patients will therefore be able to treat themselves at home in the future.